Acute Coronary Syndromes: Clinical Trials

21 trials for Acute Coronary Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 4 unknown, 3 recruiting, 1 not yet recruiting. 21 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 421Completed 13, Unknown 4, Recruiting 3, Not yet recruiting 1

Follow Acute Coronary Syndromes: new trials by email Literature Review of Acute Coronary Syndromes trials Research Report on Acute Coronary Syndromes

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome
bempedoic acid, Ezetimibe, High-Intensity Statin Therapy - Acute Coronary Syndromes, Dyslipidemia
Phase 4RecruitingTaipei Medical University Hospital4002026-08-262026-09-17
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Early P2Y12 Inhibitor Monotherapy, Standard Dual Antiplatelet Therapy - Acute Coronary Syndromes, STEMI
Phase 4RecruitingGyeongsang National University Hospital22002026-07-012026-11-05
Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes
Anticoagulant Therapy - Percutaneous Coronary Intervention, High Bleeding Risk
Phase 4Not yet recruitingShenyang Northern Hospital52702026-02-012026-02-03
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Rosuvastatin 20 mg/day, Atorvastatin 40 mg - Acute Coronary Syndromes
Phase 4RecruitingKing Edward Medical University1522025-01-052025-03-11
DUAL Antithrombotic Therapy in Patients With AF and ACS
Rivaroxaban 15 MG Oral Tablet, Clopidogrel 75 Mg Oral Tablet, Ticagrelor 90 MG Oral Tablet - Atrial Fibrillation, Acute Coronary Syndromes
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine40002019-10-012019-07-17
Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
Chewing Ticagrelor, Oral Ticagrelor - Acute Coronary Syndromes, ST Elevation Myocardial Infarction
Phase 4CompletedSheba Medical Center502016-05-012017-01-10
Cocktail Injection Improves Outcomes of FFR Guided PCI
cocktail, FFR, QCA guided group - Acute Coronary Syndromes
Phase 4UnknownXijing Hospital5002015-10-012015-10-30
Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study
Sub Lingual Ticagrelor - Acute Coronary Syndromes, Non ST Elevation Myocardial Infarction
Phase 4CompletedSheba Medical Center502015-07-012016-03-22
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Apixaban, vitamin K antagonist, Acetylsalicylic acid - Acute Coronary Syndromes
Phase 4CompletedBristol-Myers Squibb46142015-06-042020-06-11
Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)
omeprazole, Pantoprazole - Acute Coronary Syndromes
Phase 4UnknownYaling Han6202012-11-012012-11-28
Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease
High dose rapamycin stent, Low dose rapamycin stent - Acute Coronary Syndromes
Phase 4UnknownShenyang Northern Hospital6062010-10-012011-08-17
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
clopidogrel, Prasugrel 10 mg - Coronary Artery Disease, Percutaneous Coronary Intervention
Phase 4CompletedLene Holmvang1062010-09-012012-10-04
Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome
Ivabradine, Placebo - Acute Coronary Syndromes
Phase 4CompletedHospital Universitario de Canarias272009-04-012020-08-11
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
aspirin, clopidogrel, aspirin, clopidogrel, cilostazol - Acute Coronary Syndromes, Percutaneous Coronary Intervention
Phase 4CompletedShenyang Northern Hospital8402009-03-012012-06-14
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
Exenatide - Hyperglycemia, Acute Coronary Syndromes
Phase 4CompletedSaint Luke's Health System402008-08-012014-11-20
Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes
coronary stent (Genous, OrbusNeich) with immobilised anti-CD34 antibody to capture circulating endothelial progenitor cells - Acute Coronary Syndromes, Coronary Heart Disease
Phase 4CompletedSilesian School of Medicine602007-10-012010-06-22
Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
Streptokinase, primary percutaneous coronary intervention - Acute Coronary Syndromes, Acute Myocardial Infarction
Phase 4CompletedIstanbul University532007-01-012009-06-23
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
cilostazol in addition to aspirin and clopidogrel - Ischemic Heart Disease, Acute Coronary Syndromes
Phase 4CompletedShenyang Northern Hospital3052006-06-012009-10-14
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
rosuvastatin, placebo, atorvastatin - Dyslipidemia, Acute Coronary Syndromes
Phase 4CompletedQueen's University182006-04-012016-03-29
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
atorvastatin,pravastatin - Ischemic Heart Disease, Acute Coronary Syndromes
Phase 4CompletedShenyang Northern Hospital13002006-02-012008-11-07

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Acute Coronary Syndrome (21)  ·  Non-ST Elevated Myocardial Infarction (3)  ·  ST Elevation Myocardial Infarction (3)  ·  Angina, Unstable (2)  ·  Dyslipidemias (2)  ·  Myocardial Ischemia (2)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Chest Pain (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Hyperglycemia (1)  ·  Inflammation (1)  ·  Myocardial Infarction (1)  ·  Reperfusion Injury (1)

Broader conditions

Cardiovascular Diseases (21)  ·  Heart Diseases (21)  ·  Vascular Diseases (21)  ·  Myocardial Ischemia (19)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Pathologic Processes (8)  ·  Infarction (5)  ·  Ischemia (5)  ·  Necrosis (5)  ·  Myocardial Infarction (4)  ·  Metabolic Diseases (3)  ·  Neurologic Manifestations (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pain (3)  ·  Signs and Symptoms (3)

Interventions

Clopidogrel (4)  ·  Atorvastatin (3)  ·  Aspirin (2)  ·  Cilostazol (2)  ·  Rosuvastatin Calcium (2)  ·  Ticagrelor (2)  ·  8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1)  ·  Exenatide (1)  ·  Ezetimibe (1)  ·  Ivabradine (1)  ·  Metoprolol (1)  ·  Morphine (1)  ·  Omeprazole (1)  ·  Pantoprazole (1)  ·  Prasugrel Hydrochloride (1)

Sponsors

Shenyang Northern Hospital (5)  ·  Sheba Medical Center (2)  ·  Bristol-Myers Squibb (1)  ·  Gyeongsang National University Hospital (1)  ·  Hospital Universitario de Canarias (1)  ·  Istanbul University (1)  ·  King Edward Medical University (1)  ·  Lene Holmvang (1)  ·  Queen's University (1)  ·  Sahlgrenska University Hospital (1)  ·  Saint Luke's Health System (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Silesian School of Medicine (1)  ·  Taipei Medical University Hospital (1)  ·  Xijing Hospital (1)

Countries

China (6)  ·  Israel (3)  ·  Canada (2)  ·  Denmark (2)  ·  Poland (2)  ·  South Korea (2)  ·  Spain (2)  ·  Sweden (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)

Top investigators

Yaling Han, M.D. (2)  ·  Ali Hussnain (1)  ·  Arif O Cimen, M.D. (1)  ·  Berrin Umman, Prof. (1)  ·  Chun-Yao Huang, MD, PhD (1)  ·  Cuneyt Turkmen, Assoc. Prof. (1)  ·  Dongdong Sun, M.D.,Ph.D. (1)  ·  Emre K Aslanger, M.D. (1)  ·  Han Yaling, MD (1)  ·  Isik Adalet, Prof. (1)  ·  Jin-Sin Koh, MD, PhD (1)  ·  Jun Jiang, PhD (1)  ·  Lene Holmvang, MD (1)  ·  Michal Tendera, MD, PhD (1)

Results publications

PMID 20817794, PMID 22323613, PMID 23186969, PMID 25110531, PMID 25197610, PMID 27719645, PMID 28018669, PMID 28068529, PMID 28150850, PMID 29071332, PMID 29898844, PMID 30883055, PMID 31147695, PMID 31557056, PMID 31707833, PMID 31809866, PMID 32223444, PMID 33283767, PMID 33461308, PMID 35115097, PMID 35172988, PMID 35612866, PMID 38876331, PMID 39197976, PMID 39502066, PMID 39557109, PMID 39918467, PMID 40117694

NIH funding

2014 (1)